{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:13:56Z","timestamp":1791360836579,"version":"4.3.1"},"reference-count":170,"publisher":"BMJ","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Opioid use disorder (OUD) is a common, treatable chronic disease that can be effectively managed in primary care settings. Untreated OUD is associated with considerable morbidity and mortality\u2014notably, overdose, infectious complications of injecting drug use, and profoundly diminished quality of life. Withdrawal management and medication tapers are ineffective and are associated with increased rates of relapse and death. Pharmacotherapy is the evidence based mainstay of OUD treatment, and many studies support its integration into primary care settings. Evidence is strongest for the opioid agonists buprenorphine and methadone, which randomized controlled trials have shown to decrease illicit opioid use and mortality. Discontinuation of opioid agonist therapy is associated with increased rates of relapse and mortality. Less evidence is available for the opioid antagonist extended release naltrexone, with a meta-analysis of randomized controlled trials showing decreased illicit opioid use but no effect on mortality. Treating OUD in primary care settings is cost effective, improves outcomes for both OUD and other medical comorbidities, and is highly acceptable to patients. Evidence on whether behavioral interventions improve outcomes for patients receiving pharmacotherapy is mixed, with guidelines promoting voluntary engagement in psychosocial supports, including counseling. Further work is needed to promote the integration of OUD treatment into primary care and to overcome regulatory barriers to integrating methadone into primary care treatment in the US.<\/jats:p>","DOI":"10.1136\/bmj.n784","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T11:15:45Z","timestamp":1621422945000},"page":"n784","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Treatment of opioid use disorder in primary care"],"prefix":"10.1136","author":[{"given":"Megan","family":"Buresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"2021051908100708000_373.may19_4.n784.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61138-0"},{"key":"2021051908100708000_373.may19_4.n784.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61611-6"},{"key":"2021051908100708000_373.may19_4.n784.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"2021051908100708000_373.may19_4.n784.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.16566"},{"key":"2021051908100708000_373.may19_4.n784.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.9308"},{"key":"2021051908100708000_373.may19_4.n784.6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"2021051908100708000_373.may19_4.n784.7","unstructured":"Centers for Disease Control, National Center for Health Statistics. National Vital Statistics Rapid Release: Provisional Drug Overdose Death Counts. 2020. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm."},{"key":"2021051908100708000_373.may19_4.n784.8","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302664"},{"key":"2021051908100708000_373.may19_4.n784.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.14.1715"},{"key":"2021051908100708000_373.may19_4.n784.10","unstructured":"Weiss L, Botsko M, Egan JE, et al. Integrating buprenorphine treatment into HIV clinical care: health and heroin use outcomes at 90-days. XVII International AIDS Conference. 3-8 August 2008, Mexico City, Mexico."},{"key":"2021051908100708000_373.may19_4.n784.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.006"},{"key":"2021051908100708000_373.may19_4.n784.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0396-x"},{"key":"2021051908100708000_373.may19_4.n784.13","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1088496"},{"key":"2021051908100708000_373.may19_4.n784.14","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30337-7"},{"key":"2021051908100708000_373.may19_4.n784.15","unstructured":"Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. SAMHSA, 2019."},{"key":"2021051908100708000_373.may19_4.n784.16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm675152e1"},{"key":"2021051908100708000_373.may19_4.n784.17","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"2021051908100708000_373.may19_4.n784.18","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.2438"},{"key":"2021051908100708000_373.may19_4.n784.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.01.014"},{"key":"2021051908100708000_373.may19_4.n784.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.02.001"},{"key":"2021051908100708000_373.may19_4.n784.21","unstructured":"Lanier D, Ko S. Screening in Primary Care Settings for Illicit Drug Use: Assessment of Screening Instruments \u2013 A Supplemental Evidence Update for the U.S. Preventive Services Task Force. 2008. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK43363\/pdf\/Bookshelf_NBK43363.pdf."},{"key":"2021051908100708000_373.may19_4.n784.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8020"},{"key":"2021051908100708000_373.may19_4.n784.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.21381"},{"key":"2021051908100708000_373.may19_4.n784.24","doi-asserted-by":"crossref","unstructured":"American Psychological Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2021051908100708000_373.may19_4.n784.25","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1990.10472544"},{"key":"2021051908100708000_373.may19_4.n784.26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004148.pub4"},{"key":"2021051908100708000_373.may19_4.n784.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.006"},{"key":"2021051908100708000_373.may19_4.n784.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7860"},{"key":"2021051908100708000_373.may19_4.n784.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7862"},{"key":"2021051908100708000_373.may19_4.n784.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108001"},{"key":"2021051908100708000_373.may19_4.n784.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01391.x"},{"key":"2021051908100708000_373.may19_4.n784.32","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300242"},{"key":"2021051908100708000_373.may19_4.n784.33","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n04_03"},{"key":"2021051908100708000_373.may19_4.n784.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2013.04.002"},{"key":"2021051908100708000_373.may19_4.n784.35","doi-asserted-by":"publisher","DOI":"10.1007\/BF02599459"},{"key":"2021051908100708000_373.may19_4.n784.36","doi-asserted-by":"publisher","DOI":"10.1007\/BF02599882"},{"key":"2021051908100708000_373.may19_4.n784.37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-8-3"},{"key":"2021051908100708000_373.may19_4.n784.38","doi-asserted-by":"publisher","DOI":"10.3109\/00952999609001678"},{"key":"2021051908100708000_373.may19_4.n784.39","doi-asserted-by":"publisher","DOI":"10.1300\/J069v26n02_01"},{"key":"2021051908100708000_373.may19_4.n784.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.07.002"},{"key":"2021051908100708000_373.may19_4.n784.41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"2021051908100708000_373.may19_4.n784.42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"2021051908100708000_373.may19_4.n784.43","first-page":"23","article-title":"Methadone and buprenorphine added to the WHO list of essential medicines","volume":"10","author":"Herget","year":"2005","journal-title":"HIV AIDS Policy Law Rev"},{"key":"2021051908100708000_373.may19_4.n784.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"2021051908100708000_373.may19_4.n784.45","doi-asserted-by":"publisher","DOI":"10.1111\/add.14188"},{"key":"2021051908100708000_373.may19_4.n784.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5475"},{"key":"2021051908100708000_373.may19_4.n784.47","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2098"},{"key":"2021051908100708000_373.may19_4.n784.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.09.007"},{"key":"2021051908100708000_373.may19_4.n784.49","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0046-2"},{"key":"2021051908100708000_373.may19_4.n784.50","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"2021051908100708000_373.may19_4.n784.51","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"2021051908100708000_373.may19_4.n784.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0571-4"},{"key":"2021051908100708000_373.may19_4.n784.53","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12201"},{"key":"2021051908100708000_373.may19_4.n784.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.09.004"},{"key":"2021051908100708000_373.may19_4.n784.55","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5302"},{"key":"2021051908100708000_373.may19_4.n784.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.12.010"},{"key":"2021051908100708000_373.may19_4.n784.57","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2003.tb05417.x"},{"key":"2021051908100708000_373.may19_4.n784.58","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701860971"},{"key":"2021051908100708000_373.may19_4.n784.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2010.01.001"},{"key":"2021051908100708000_373.may19_4.n784.60","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000457"},{"key":"2021051908100708000_373.may19_4.n784.61","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13069"},{"key":"2021051908100708000_373.may19_4.n784.62","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S109919"},{"key":"2021051908100708000_373.may19_4.n784.63","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000323"},{"key":"2021051908100708000_373.may19_4.n784.64","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"2021051908100708000_373.may19_4.n784.65","doi-asserted-by":"publisher","DOI":"10.1111\/add.14991"},{"key":"2021051908100708000_373.may19_4.n784.66","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-014-9924-1"},{"key":"2021051908100708000_373.may19_4.n784.67","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0050-y"},{"key":"2021051908100708000_373.may19_4.n784.68","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2018.0163"},{"key":"2021051908100708000_373.may19_4.n784.69","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0204"},{"key":"2021051908100708000_373.may19_4.n784.70","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.638734"},{"key":"2021051908100708000_373.may19_4.n784.71","doi-asserted-by":"publisher","DOI":"10.1370\/afm.665"},{"key":"2021051908100708000_373.may19_4.n784.72","doi-asserted-by":"publisher","DOI":"10.1086\/500200"},{"key":"2021051908100708000_373.may19_4.n784.73","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820a8226"},{"key":"2021051908100708000_373.may19_4.n784.74","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-3993-2"},{"key":"2021051908100708000_373.may19_4.n784.75","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.2556"},{"key":"2021051908100708000_373.may19_4.n784.76","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2149"},{"key":"2021051908100708000_373.may19_4.n784.77","unstructured":"Center for Substance Abuse Treatment . Substance Abuse Treatment: Group Therapy. Treatment Improvement Protocol (TIP) Series, No. 41. Substance Abuse and Mental Health Services Administration, 2005."},{"key":"2021051908100708000_373.may19_4.n784.78","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701860971"},{"key":"2021051908100708000_373.may19_4.n784.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2009.05.003"},{"key":"2021051908100708000_373.may19_4.n784.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.12.010"},{"key":"2021051908100708000_373.may19_4.n784.81","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318209751e"},{"key":"2021051908100708000_373.may19_4.n784.82","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182097537"},{"key":"2021051908100708000_373.may19_4.n784.83","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.541"},{"key":"2021051908100708000_373.may19_4.n784.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.06.010"},{"key":"2021051908100708000_373.may19_4.n784.85","unstructured":"Primary Care Collaborative. Vermont Hub and Spokes Health Homes. 2019. https:\/\/www.pcpcc.org\/initiative\/vermont-hub-and-spokes-health-homes."},{"key":"2021051908100708000_373.may19_4.n784.86","unstructured":"Project Echo. Behavioral Health and Addiction (BHA). 2021. https:\/\/echo.unm.edu\/teleecho-programs\/bha."},{"key":"2021051908100708000_373.may19_4.n784.87","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1129388"},{"key":"2021051908100708000_373.may19_4.n784.88","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16070792"},{"key":"2021051908100708000_373.may19_4.n784.89","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.121"},{"key":"2021051908100708000_373.may19_4.n784.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.07.005"},{"key":"2021051908100708000_373.may19_4.n784.91","doi-asserted-by":"publisher","DOI":"10.1111\/add.12266"},{"key":"2021051908100708000_373.may19_4.n784.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055255"},{"key":"2021051908100708000_373.may19_4.n784.93","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.16.2.132"},{"key":"2021051908100708000_373.may19_4.n784.94","doi-asserted-by":"publisher","DOI":"10.1037\/a0037496"},{"key":"2021051908100708000_373.may19_4.n784.95","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.2.340"},{"key":"2021051908100708000_373.may19_4.n784.96","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e318233d621"},{"key":"2021051908100708000_373.may19_4.n784.97","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2019.0242"},{"key":"2021051908100708000_373.may19_4.n784.98","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/24.1.38"},{"key":"2021051908100708000_373.may19_4.n784.99","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1967.00300010021004"},{"key":"2021051908100708000_373.may19_4.n784.100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208"},{"key":"2021051908100708000_373.may19_4.n784.101","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00097-0"},{"key":"2021051908100708000_373.may19_4.n784.102","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2010.0034"},{"key":"2021051908100708000_373.may19_4.n784.103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.14.1724"},{"key":"2021051908100708000_373.may19_4.n784.104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112328"},{"key":"2021051908100708000_373.may19_4.n784.105","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00040-0"},{"key":"2021051908100708000_373.may19_4.n784.106","first-page":"31","article-title":"Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study","volume":"49","author":"Gossop","year":"1999","journal-title":"Br J Gen Pract"},{"key":"2021051908100708000_373.may19_4.n784.107","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2012.694516"},{"key":"2021051908100708000_373.may19_4.n784.108","doi-asserted-by":"publisher","DOI":"10.1111\/add.13087"},{"key":"2021051908100708000_373.may19_4.n784.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.12.009"},{"key":"2021051908100708000_373.may19_4.n784.110","unstructured":"Substances Abuse and Mental Health Services Administration. Methadone. 2020. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions\/methadone."},{"key":"2021051908100708000_373.may19_4.n784.111","unstructured":"Alderks CE . Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update). In: The CBHSQ Report. Substance Abuse and Mental Health Services Administration, 2013."},{"key":"2021051908100708000_373.may19_4.n784.112","doi-asserted-by":"publisher","DOI":"10.1007\/BF02350965"},{"key":"2021051908100708000_373.may19_4.n784.113","doi-asserted-by":"publisher","DOI":"10.1097\/01.adt.0000210713.80198.d1"},{"key":"2021051908100708000_373.may19_4.n784.114","doi-asserted-by":"publisher","DOI":"10.1097\/ADT.0b013e31802b4ea1"},{"key":"2021051908100708000_373.may19_4.n784.115","doi-asserted-by":"publisher","DOI":"10.1300\/J069v22n03_03"},{"key":"2021051908100708000_373.may19_4.n784.116","doi-asserted-by":"publisher","DOI":"10.3109\/10826089409048714"},{"key":"2021051908100708000_373.may19_4.n784.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.07.014"},{"key":"2021051908100708000_373.may19_4.n784.118","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17070732"},{"key":"2021051908100708000_373.may19_4.n784.119","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60358-9"},{"key":"2021051908100708000_373.may19_4.n784.120","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"2021051908100708000_373.may19_4.n784.121","doi-asserted-by":"publisher","DOI":"10.1111\/add.14180"},{"key":"2021051908100708000_373.may19_4.n784.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.031"},{"key":"2021051908100708000_373.may19_4.n784.123","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1700265"},{"key":"2021051908100708000_373.may19_4.n784.124","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16050548"},{"key":"2021051908100708000_373.may19_4.n784.125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11380-5"},{"key":"2021051908100708000_373.may19_4.n784.126","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02536-6"},{"key":"2021051908100708000_373.may19_4.n784.127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03515.x"},{"key":"2021051908100708000_373.may19_4.n784.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.10.012"},{"key":"2021051908100708000_373.may19_4.n784.129","doi-asserted-by":"publisher","DOI":"10.1111\/add.13089"},{"key":"2021051908100708000_373.may19_4.n784.130","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0276-0"},{"key":"2021051908100708000_373.may19_4.n784.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.06.005"},{"key":"2021051908100708000_373.may19_4.n784.132","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.12.009"},{"key":"2021051908100708000_373.may19_4.n784.133","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61127-7"},{"key":"2021051908100708000_373.may19_4.n784.134","first-page":"463","article-title":"Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021051908100708000_373.may19_4.n784.135","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000098"},{"key":"2021051908100708000_373.may19_4.n784.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.05.016"},{"key":"2021051908100708000_373.may19_4.n784.137","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002562"},{"key":"2021051908100708000_373.may19_4.n784.138","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002235"},{"key":"2021051908100708000_373.may19_4.n784.139","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5734"},{"key":"2021051908100708000_373.may19_4.n784.140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"2021051908100708000_373.may19_4.n784.141","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2009.9987"},{"key":"2021051908100708000_373.may19_4.n784.142","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1566295"},{"key":"2021051908100708000_373.may19_4.n784.143","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701204813"},{"key":"2021051908100708000_373.may19_4.n784.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.06.024"},{"key":"2021051908100708000_373.may19_4.n784.145","doi-asserted-by":"publisher","DOI":"10.1080\/10826080500260800"},{"key":"2021051908100708000_373.may19_4.n784.146","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000199"},{"key":"2021051908100708000_373.may19_4.n784.147","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31826741aa"},{"key":"2021051908100708000_373.may19_4.n784.148","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.003"},{"key":"2021051908100708000_373.may19_4.n784.149","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00436-7"},{"key":"2021051908100708000_373.may19_4.n784.150","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw416"},{"key":"2021051908100708000_373.may19_4.n784.151","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"2021051908100708000_373.may19_4.n784.152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.01.017"},{"key":"2021051908100708000_373.may19_4.n784.153","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1123"},{"key":"2021051908100708000_373.may19_4.n784.154","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1715"},{"key":"2021051908100708000_373.may19_4.n784.155","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa105"},{"key":"2021051908100708000_373.may19_4.n784.156","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30404-1"},{"key":"2021051908100708000_373.may19_4.n784.157","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1089"},{"key":"2021051908100708000_373.may19_4.n784.158","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.181506"},{"key":"2021051908100708000_373.may19_4.n784.159","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"2021051908100708000_373.may19_4.n784.160","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"2021051908100708000_373.may19_4.n784.161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.05.001"},{"key":"2021051908100708000_373.may19_4.n784.162","unstructured":"US Department of Health and Human Services. HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. 2019. https:\/\/www.hhs.gov\/opioids\/treatment\/clinicians-guide-opioid-dosage-reduction\/index.html."},{"key":"2021051908100708000_373.may19_4.n784.163","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.004"},{"key":"2021051908100708000_373.may19_4.n784.164","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1488"},{"key":"2021051908100708000_373.may19_4.n784.165","first-page":"1","volume":"14","year":"2020","journal-title":"J Addict Med"},{"key":"2021051908100708000_373.may19_4.n784.166","unstructured":"Substance Abuse and Mental Health Services Administration . Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. Treatment Improvement Protocol (TIP) Series, No. 63. SAMHSA, 2018."},{"key":"2021051908100708000_373.may19_4.n784.167","unstructured":"Canadian Research Initiative in Substance Misuse. National Guideline for the Clinical Management of Opioid Use Disorder. 2018. https:\/\/crism.ca\/wp-content\/uploads\/2018\/03\/CRISM_NationalGuideline_OUD-ENG.pdf."},{"key":"2021051908100708000_373.may19_4.n784.168","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32259-1"},{"key":"2021051908100708000_373.may19_4.n784.169","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.1052"},{"key":"2021051908100708000_373.may19_4.n784.170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.11.004"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.n784","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.n784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:36:43Z","timestamp":1621438603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.n784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":170,"alternative-id":["10.1136\/bmj.n784"],"URL":"https:\/\/doi.org\/10.1136\/bmj.n784","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]}}}